Literature DB >> 30061048

Negative trials in critical care: why most research is probably wrong.

John G Laffey1, Brian P Kavanagh2.   

Abstract

Mesh：

Year:  2018        PMID： 30061048     DOI： 10.1016/S2213-2600(18)30279-0

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  16 in total

1.  Less is more in critical care is supported by evidence-based medicine.

Authors:  Catherine L Auriemma; Greet Van den Berghe; Scott D Halpern
Journal:  Intensive Care Med       Date:  2019-09-18       Impact factor: 17.440

Review 2.  Time to stop randomized and large pragmatic trials for intensive care medicine syndromes: the case of sepsis and acute respiratory distress syndrome.

Authors:  Armand R J Girbes; Harm-Jan de Grooth
Journal:  J Thorac Dis       Date:  2020-02       Impact factor: 2.895

3.  One-year patient outcomes based on lung morphology in acute respiratory distress syndrome: secondary analysis of LIVE trial.

Authors:  Florian Blanchard; Thomas Godet; Stephanie Pons; Natacha Kapandji; Matthieu Jabaudon; Vincent Degos; Lucile Borao; Adrien Bougle; Antoine Monsel; Emmanuel Futier; Jean-Michel Constantin; Arthur James
Journal:  Crit Care       Date:  2022-06-04       Impact factor: 19.334

4.  Feasibility of Extracting Meaningful Patient Centered Outcomes From the Electronic Health Record Following Critical Illness in the Elderly.

Authors:  Sumera R Ahmad; Alex D Tarabochia; Luann Budahn; Allison M Lemahieu; Brenda Anderson; Kirtivardhan Vashistha; Lioudmila Karnatovskaia; Ognjen Gajic
Journal:  Front Med (Lausanne)       Date:  2022-06-06

5.  Metabolomic basis for response to high dose vitamin D in critical illness.

Authors:  Karin Amrein; Jessica A Lasky-Su; Harald Dobnig; Kenneth B Christopher
Journal:  Clin Nutr       Date:  2020-09-28       Impact factor: 7.324

Review 6.  Gene Therapy for Acute Respiratory Distress Syndrome.

Authors:  Jing Liu; David A Dean
Journal:  Front Physiol       Date:  2022-01-17       Impact factor: 4.566

7.  Variable Ventilation Is Equally Effective as Conventional Pressure Control Ventilation for Optimizing Lung Function in a Rabbit Model of ARDS.

Authors:  Gergely H Fodor; Sam Bayat; Gergely Albu; Na Lin; Aurélie Baudat; Judit Danis; Ferenc Peták; Walid Habre
Journal:  Front Physiol       Date:  2019-06-26       Impact factor: 4.566

8.  Is chest imaging relevant in diagnosing acute respiratory distress syndrome in polytrauma patients? A population-based cohort study.

Authors:  Karlijn Julia Patricia van Wessem; Luke Petrus Hendrikus Leenen
Journal:  Eur J Trauma Emerg Surg       Date:  2019-08-10       Impact factor: 3.693

9.  Six-month and 12-month patient outcomes based on inflammatory subphenotypes in sepsis-associated ARDS: secondary analysis of SAILS-ALTOS trial.

Authors:  Mohamed D Hashem; Ramona O Hopkins; Elizabeth Colantuoni; Victor D Dinglas; Pratik Sinha; Lisa Aronson Friedman; Peter E Morris; James C Jackson; Catherine L Hough; Carolyn S Calfee; Dale M Needham
Journal:  Thorax       Date:  2021-06-10       Impact factor: 9.139

10.  Emerging pharmacological therapies for ARDS: COVID-19 and beyond.

Authors:  Shahd Horie; Bairbre McNicholas; Emanuele Rezoagli; Tài Pham; Ger Curley; Danny McAuley; Cecilia O'Kane; Alistair Nichol; Claudia Dos Santos; Patricia R M Rocco; Giacomo Bellani; John G Laffey
Journal:  Intensive Care Med       Date:  2020-07-11       Impact factor: 41.787
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.